FMCNA

Renal Care Group, Inc. (Nasdaq/NM:RCGI - news) today announced results for the first quarter ended March 31, 2000.

Mr. Sam Brooks, president and chief executive officer of Renal Care Group, Inc., said, ``Consistency, profitability and strong operating performance are the hallmarks of our company and major contributors to an exceptional first quarter. This quarter is our 17th consecutive quarter in which earnings per share increased 20% or more. We are pleased with our performance and grateful to the many healthcare professionals in our 186 dialysis facilities who made it possible.''

Revenues for the quarter ended March 31, 2000, increased 19% to $144.3 million compared with revenues of $120.9 million for the same period in 1999. Net income before merger expenses increased 26% to $15.1 million, or $0.32 per share, an increase of 23% in earnings per share over the same period last year.

Same-store treatment and same-store revenue growth were 8.4% and 12.7%, respectively, for the three months ended March 31, 2000. In addition, in April 2000, the Company completed the previously announced acquisition of Renal Disease Management by Physicians, Inc. of Youngstown, Ohio. The acquisition will be treated as a pooling of interests for accounting purposes.

Mr. Brooks added, ``We interpret the solid results achieved in the first quarter as confirmation of our expectations for continued strong performance throughout the remainder of the year. In short, we believe the Company is well positioned to improve the quality of life for dialysis patients and reward its shareholders.''

Renal Care Group, Inc. is a dialysis services company that provides care to patients with kidney disease. The Company treats approximately 15,000 patients through 186 dialysis centers, in addition to providing acute dialysis services in 104 hospitals. Over 5,000 associates provide services in the Company's 23-state network.

Certain statements in this press release constitute ``forward-looking statements'' within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect management's expectations and are based upon currently available information. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Renal Care Group to differ materially from those expressed in or implied by the forward-looking statements. These factors are discussed in more detail in the Company's reports filed with the Securities and Exchange Commission, including without limitation Renal Care Group's annual report on Form 10-K for the year ended December 31, 1999. Copies of these filings are available from Renal Care Group upon request.

RENAL CARE GROUP, INC.
Unaudited Consolidated Income Statements
(In thousands, except per share data)

Three Months Ended March 31,	2000	1999
Net revenue	$144,297	$120,861
Operating costs and expenses	109,250	92,742
Depreciation and amortization	7,404	6,163
Income from operations	27,643	21,956
Interest expense, net	1,191	1,405
Income before merger expenses minority interest and taxes	26,452	20,551
Minority interest	2,169	1,500
Net income before merger expenses and income taxes	24,283	19,051
Income taxes	9,229	7,144
Net income before merger expenses	_ $15,054	$11,907
Diluted earnings per share before merger expenses	$0.32	$0.26
Net income after merger expenses	$15,054	$8,107
Diluted earnings per share after merger expenses	$0.32	$0.17
Weighted average shares outstanding	46,900	46,400